Beauty Independent reported on 29 September 2026 that The Outset has shut down. Source: https://www.beautyindependent.com/scarlett-johansson-skincare-brand-the-outset-shuts-down/.
The reported detail is worth laying out, because almost all of it describes advantages. Founded March 2022. Launched at Sephora the following month across 500 doors. Around 14 SKUs at close, priced $32 to $54. Projected first-year retail sales of $10m, with 2025 estimated sales of $10m to $25m. Investor funding of $5m to $10m from The Najafi Companies. 438,000 Instagram followers and roughly 610,000 on TikTok with 18 million likes. Discounts of up to 50% in the period before closing.
A brand at £500k to £5m reading that list is reading a description of everything it is trying to get. Five hundred Sephora doors in month two. A million followers across platforms. Funding. A famous founder.
It closed in four and a half years.
What those advantages actually buy
Distribution and reach do one thing extremely well. They generate trial.
Five hundred doors puts the product in front of an enormous number of people. A million followers means a launch is seen. Together they solve the problem that genuinely kills most small brands, which is that nobody knows you exist.
What neither does is make someone buy again. Reach is a first-purchase instrument. Repeat purchase comes from the product doing something the customer notices, at a price they think is fair, in a routine they maintain. No amount of distribution affects any of those variables.
This is why a brand can have an excellent launch year and a structurally weak business. The launch number measures how many people tried it. The second year measures how many liked it enough to come back, and that is the number that determines whether there is a business.
The discounting detail tells you where it went
Up to 50% off before closing is the part of the reporting that describes the mechanism rather than the outcome.
Deep discounting late in a brand's life is usually a response to a specific problem: inventory bought against a demand forecast that assumed repeat purchase which did not materialise. You order to a plan, the reorders do not come, and you are left holding stock that has to move.
The discount then does damage of its own. It teaches the remaining customers that full price is optional, it devalues the brand in the eyes of the retailer, and it trains the exact behaviour that makes recovery harder. It is a rational short-term move that accelerates the underlying problem.
For a founder, the useful signal is that heavy discounting is rarely the start of trouble. It is the visible stage of something that began a year or more earlier in the repeat purchase rate.
Fourteen SKUs at $32 to $54
Worth noting that this was not an over-extended range. Fourteen products in a tight price band is disciplined by the standards of the category.
Which rules out one of the usual explanations and points at the harder one. The issue was not that the range was confusing or the price architecture incoherent. It was that enough people did not come back.
In skincare, that generally traces to one of three things. The product did not visibly do enough for the customer to attribute a result to it. It did, but nothing in the experience prompted a reorder at the right moment. Or the customer liked it and found something equivalent cheaper, which in a market with a well-developed dupe culture is a live risk at $32 to $54.
Any of those is solvable. None is solvable with more distribution.
The celebrity founder question
It would be easy to read this as a story about celebrity brands and stop there. That reading is too comfortable.
A famous founder is a reach advantage, and we have just established that reach is not the binding constraint. So a celebrity brand failing is not evidence that celebrity brands do not work. It is evidence that the thing they are good at is not the thing that matters most.
The same logic applies to a founder with a large personal following, a brand with a viral moment, or one with an unusually successful launch. All of those are the same asset: efficient trial. All of them leave the second purchase entirely unsolved.
The two numbers to pull this week
Repeat purchase rate within twelve months. What share of people who bought once bought again inside a year. For most skincare brands at this size a healthy number is meaningfully above a quarter, and founders are regularly surprised by how far below that they are.
Share of revenue from discounted orders. Include your standard welcome code, your sale events and your affiliate codes, because customers do not distinguish between them. If a large share of your revenue never transacts at full price, your stated price is not your actual price, and your margin plan is fiction.
Those two numbers tell you whether you have a business that compounds. Follower count and door count tell you how quickly you can acquire people who will find that out.
The plain version
The brand had the launch most founders would trade several years for, and it was not enough.
What is worth taking from that is not pessimism. It is a reordering of priorities. If you are spending the next quarter chasing distribution and reach while your repeat purchase rate is weak, you are buying more people the chance to not come back.
Fix the second purchase first. The reach is the easier problem and it will still be there.